Examples in treatment of solid tumors include ERBB2 (HER2) gene amplification in breast and gastric cancer, EGFR mutation in non-small cell lung cancer, and KRAS mutation in colorectal cancer [18], [19], [20], [21]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.